Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0SL, United Kingdom.
Internal Medicine Research Unit, Pfizer Inc., Cambridge, MA 02139.
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27). doi: 10.1073/pnas.2106868118.
An acute increase in the circulating concentration of glucocorticoid hormones is essential for the survival of severe somatic stresses. Circulating concentrations of GDF15, a hormone that acts in the brain to reduce food intake, are frequently elevated in stressful states. We now report that GDF15 potently activates the hypothalamic-pituitary-adrenal (HPA) axis in mice and rats. A blocking antibody to the GDNF-family receptor α-like receptor completely prevented the corticosterone response to GDF15 administration. In wild-type mice exposed to a range of stressful stimuli, circulating levels of both corticosterone and GDF15 rose acutely. In the case of or lipopolysaccharide injections, the vigorous proinflammatory cytokine response elicited was sufficient to produce a near-maximal HPA response, regardless of the presence or absence of GDF15. In contrast, the activation of the HPA axis seen in wild-type mice in response to the administration of genotoxic or endoplasmic reticulum toxins, which do not provoke a marked rise in cytokines, was absent in mice. In conclusion, consistent with its proposed role as a sentinel hormone, endogenous GDF15 is required for the activation of the protective HPA response to toxins that do not induce a substantial cytokine response. In the context of efforts to develop GDF15 as an antiobesity therapeutic, these findings identify a biomarker of target engagement and a previously unrecognized pharmacodynamic effect, which will require monitoring in human studies.
循环中糖皮质激素浓度的急性增加对于严重躯体应激的生存至关重要。作用于大脑以减少食物摄入的激素 GDF15,在应激状态下经常升高。我们现在报告 GDF15 在小鼠和大鼠中强烈激活下丘脑-垂体-肾上腺 (HPA) 轴。一种针对 GDNF 家族受体 α 样受体的阻断抗体完全阻止了 GDF15 给药对皮质酮反应。在暴露于一系列应激刺激的野生型小鼠中,循环中的皮质酮和 GDF15 水平均急剧升高。在注射或脂多糖的情况下,引发的强烈促炎细胞因子反应足以产生近乎最大的 HPA 反应,无论是否存在 GDF15。相比之下,在对遗传毒性或内质网毒素给药做出反应的野生型小鼠中观察到的 HPA 轴激活在 小鼠中不存在,而这些毒素不会引起细胞因子明显升高。总之,与作为哨兵激素的预期作用一致,内源性 GDF15 是对不诱导明显细胞因子反应的毒素激活保护性 HPA 反应所必需的。在将 GDF15 开发为抗肥胖治疗药物的背景下,这些发现确定了一个靶标参与的生物标志物和以前未被认识到的药效学效应,这在人类研究中需要进行监测。